Zobrazeno 1 - 10
of 10 718
pro vyhledávání: '"Gascoyne, RD"'
Autor:
Dunphy CH
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2001 Mar; Vol. 14 (3), pp. 263-4.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Modern Pathology 1 March 2001 14(3):263-264
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alduaij W; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; UBC Clinician Investigator Program, The University of British Columbia, Vancouver, BC, Canada., Collinge B; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Ben-Neriah S; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Jiang A; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Hilton LK; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Boyle M; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Meissner B; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Chong L; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Miyata-Takata T; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Slack GW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Farinha P; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Craig JW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Lytle A; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Savage KJ; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Villa D; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Gerrie AS; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Freeman CL; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Gascoyne RD; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Connors JM; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Morin RD; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada., Sehn LH; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada., Steidl C; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
Blood [Blood] 2023 May 18; Vol. 141 (20), pp. 2493-2507.
Autor:
Nissen MD; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada., Kusakabe M; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada., Wang X; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada., Simkin G; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada., Gracias D; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada., Tyshchenko K; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada., Hill A; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada., Meskas J; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada., Hung S; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada., Chavez EA; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada., Ennishi D; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada., Aoki T; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada., Sarkozy C; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada., Connors JM; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada., Farinha P; Department of Pathology and Lab Medicine, BC Cancer Agency, Vancouver, Canada., Slack GW; Department of Pathology and Lab Medicine, BC Cancer Agency, Vancouver, Canada., Gascoyne RD; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada.; Department of Pathology and Lab Medicine, BC Cancer Agency, Vancouver, Canada., Brinkman RR; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada., Steidl C; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada., Weng AP; Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada.; Department of Pathology and Lab Medicine, BC Cancer Agency, Vancouver, Canada.
Publikováno v:
Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2020 Jun; Vol. 97 (6), pp. 620-629. Date of Electronic Publication: 2019 Oct 22.
Autor:
Cheng PTM; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Villa D; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Gerrie AS; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Freeman CL; H Lee Moffitt Cancer Centre & Research Institute, Tampa, FL., Slack GW; Centre for Lymphoid Cancer and Department of Pathology, BC Cancer, Vancouver, BC, Canada., Gascoyne RD; Centre for Lymphoid Cancer and Department of Pathology, BC Cancer, Vancouver, BC, Canada., Farinha P; Centre for Lymphoid Cancer and Department of Pathology, BC Cancer, Vancouver, BC, Canada., Craig JW; Centre for Lymphoid Cancer and Department of Pathology, BC Cancer, Vancouver, BC, Canada., Skinnider B; Centre for Lymphoid Cancer and Department of Pathology, BC Cancer, Vancouver, BC, Canada., Wilson D; Division of Radiology, BC Cancer, Vancouver, BC, Canada., Scott DW; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Connors JM; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Sehn LH; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Savage KJ; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
Publikováno v:
Blood advances [Blood Adv] 2022 Nov 22; Vol. 6 (22), pp. 5924-5932.
Autor:
Takata K; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.; Division of Molecular and Cellular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Chong LC; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Ennishi D; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Aoki T; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Li MY; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Thakur A; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.; Terry Fox Laboratory, British Columbia Cancer, Vancouver, British Columbia, Canada., Healy S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Viganò E; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Dao T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kwon D; Department of Molecular Oncology and., Duns G; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Nielsen JS; Trev and Joyce Deeley Research Centre, British Columbia Cancer, Vancouver, British Columbia, Canada., Ben-Neriah S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Tse E; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Hung SS; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Boyle M; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Mun SS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bourne CM; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Woolcock B; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Telenius A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Kishida M; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Rai S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Zhang AW; Department of Molecular Oncology and., Bashashati A; Department of Molecular Oncology and., Saberi S; Department of Molecular Oncology and., D'Antonio G; Trev and Joyce Deeley Research Centre, British Columbia Cancer, Vancouver, British Columbia, Canada., Nelson BH; Trev and Joyce Deeley Research Centre, British Columbia Cancer, Vancouver, British Columbia, Canada., Shah SP; Department of Molecular Oncology and.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Hoodless PA; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.; Terry Fox Laboratory, British Columbia Cancer, Vancouver, British Columbia, Canada., Melnick AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Gascoyne RD; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Connors JM; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Scheinberg DA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Béguelin W; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Scott DW; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Steidl C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2022 May 16; Vol. 132 (10).
Autor:
Johnston RL; British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, QLD, Australia., Mottok A; British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Institute of Pathology, University Hospital Giessen and Marburg GmbH, Giessen, Germany., Chan FC; British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada., Jiang A; British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Diepstra A; Department of Pathology & Medical Biology, University of Groningen, Groningen, The Netherlands., Visser L; Department of Pathology & Medical Biology, University of Groningen, Groningen, The Netherlands., Telenius A; British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada., Gascoyne RD; British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Friedman DL; Department of Pediatrics, Vanderbilt-Ingram Cancer Center, Nashville, TN., Schwartz CL; Pediatric Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI., Kelly KM; Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY; and., Scott DW; British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada., Horton TM; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX., Steidl C; British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
Blood [Blood] 2022 Feb 10; Vol. 139 (6), pp. 889-893.
Autor:
Ramis-Zaldivar JE; Hematopathology Unit, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid., Gonzalez-Farre B; Hematopathology Unit, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid., Nicolae A; Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda., Pack S; Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda., Clot G; Hematopathology Unit, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid., Nadeu F; Hematopathology Unit, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid., Mottok A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver., Horn H; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tübingen., Song JY; Department of Pathology, City of Hope National Medical Center, Duarte., Fu K; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha., Wright G; Biometric Research Branch, Division of Cancer Diagnosis and Treatment, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gascoyne RD; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver., Chan WC; Department of Pathology, City of Hope National Medical Center, Duarte., Scott DW; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; Department of Medicine, University of British Columbia, Vancouver., Feldman AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Valera A; Hematopathology Unit, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona., Enjuanes A; Hematopathology Unit, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid., Braziel RM; Department of Clinical Pathology, Oregon Health and Science University, Oregon., Smeland EB; Department of Immunology and Centre for Cancer Biomedicine, University of Oslo and Oslo University Hospital, Oslo., Staudt LM; Lymphoid Malignancies Branch, Center for Cancer Research, National Institutes of Health, Bethesda., Rosenwald A; Institute of Pathology, University of Wuerzburg, Wuerzburg., Rimsza LM; Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix., Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tübingen., Jaffe ES; Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda., Salaverria I; Hematopathology Unit, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid., Campo E; Hematopathology Unit, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid. ecampo@clinic.cat.
Publikováno v:
Haematologica [Haematologica] 2021 Oct 01; Vol. 106 (10), pp. 2682-2693. Date of Electronic Publication: 2021 Oct 01.